84-6221-91 Vesicular stomatitis Indiana virus Matrix (FITC) 100ul 581145
特徴
- Plays a major role in assembly and budding of virion.
- Condensates the ribonucleocapsid core during virus assembly.
- Shut off cellular transcription by inhibiting mRNA nuclear export through direct interaction with host RAE1-NUP98 complex.
- This shut off presumably inhibit interferon signaling and thus establishment of antiviral state in virus infected cells.
- Induces cell-rounding, cytoskeleton disorganization and apoptosis in infected cell (By similarity).
- Applications:Suitable for use in FLISA.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:Store product at 4°C if to be used immediately within two weeks.
- For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C.
- Aliquots are stable at -20°C for 12 months after receipt.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- Caution: FITC conjugates are sensitive to light.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:Vesicular stomatitis Indiana virus (strain Glasgow) (VSIV)
- Grade:Affinity Purified
- Purity:Purified by Protein G affinity chromatography.
- Form:Supplied as a liquid in 0.01M PBS, pH 7.4, 0.03% Proclin 300, 50% glycerol. Labeled with Fluorescein isothiocyanate (FITC).
- Specificity:Recognizes Vesicular stomatitis Indiana virus (strain Glasgow) (VSIV) M.
- Isotype:IgG
- Calc Applications Abbrev:FLISA
- Immunogen:Recombinant protein corresponding to aa1-23 from vesicular stomatitis Indiana virus matrix protein.
- Shelf Life:1year
- Swiss Prot Number:P04876
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]